Koyfin Home > Directory > Health Care > Amneal Pharmaceuticals Inc > Total Debt / (EBITDA-CAPEX)

Amneal Pharmaceuticals Inc Total Debt / (EBITDA-CAPEX) Chart (AMRX)

Amneal Pharmaceuticals Inc annual/quarterly Total Debt / (EBITDA-CAPEX) from 2016 to 2018.
  • Amneal Pharmaceuticals Inc Total Debt / (EBITDA-CAPEX) for the quarter ending December 12, 2018 was $8m a 25.75% increase of 2m year over year
  • Amneal Pharmaceuticals Inc Total Debt / (EBITDA-CAPEX) for the last 12 months ending December 12, 2018 was $8m a 23.53% increase of 2m year over year
  • Amneal Pharmaceuticals Inc Annual Total Debt / (EBITDA-CAPEX) for 2018 was $8m a 8.94% increase of 1m from 2017
  • Amneal Pharmaceuticals Inc Annual Total Debt / (EBITDA-CAPEX) for 2017 was $7m a 12.42% increase of 1m from 2016
  • Amneal Pharmaceuticals Inc Annual Total Debt / (EBITDA-CAPEX) for 2016 was $7m a -14.97% decrease of -1m from 2015
Other Ratios Metrics:
  • Amneal Pharmaceuticals Inc Total Debt / Capital for the quarter ending December 12, 2018 was $75m a -77.49% decrease of -58m year over year
  • Amneal Pharmaceuticals Inc Other Liabilities for the quarter ending December 12, 2018 was $233m a 90.39% increase of 210m year over year
  • Amneal Pharmaceuticals Inc Total Debt / Equity for the quarter ending December 12, 2018 was $300m
View Chart On Koyfin

Quarterly AMRX Total Debt / (EBITDA-CAPEX) Data

12/2018$8m
09/2018$7m
06/2018$8m
03/2018$6m
12/2017$5m
09/2017$7m
03/2017$10m
12/2016$4m

Annual AMRX Total Debt / (EBITDA-CAPEX) Data

2018$8m
2017$7m
2016$7m
2015$7m